ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

First Lady Recalls 1992 Meeting With NBCC, Credits Group For Progress In Breast Cancer

May 8, 1998

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993

Eight applications Received For NSABP chairman

September 9, 1994

In Brief: Bast To Head M.D. Anderson Medicine Dib.; Ozer Named Emory Cancer Center Director

April 8, 1994

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

Program Committee Lists 10 Papers At AACR Meeting

July 19, 1985